NCT02068352View on ClinicalTrials.gov

A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

June 20, 2014

Primary Completion Date

January 28, 2015

Study Completion Date

February 3, 2015

Conditions
Atopic Dermatitis
Interventions
DRUG

OPA-15406

OPA-15406 topical ointment

DRUG

Vehicle ointment

OPA-15406 1%-matching placebo topical ointment

Trial Locations (30)

5073

Hectorville

11790

Stony Brook

23507

Norfolk

27262

High Point

32065

Orange Park

33401

West Palm Beach

33613

Tampa

46032

Carmel

48109

Ann Arbor

60005

Arlington Heights

77065

Houston

77845

College Station

78229

San Antonio

78759

Austin

80220

Denver

87106

Albuquerque

90045

Los Angeles

92123

San Diego

99204

Spokane

07044

Verona

97239-4501

Portland

Unknown

Phillip

Kogarah

Woolloongabba

Fremantle

Katowice

Krakow

Lodz

Warsaw

Wroclaw

All Listed Sponsors
lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT02068352 - A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis | Biotech Hunter | Biotech Hunter